Navigation Links
New insights into mushroom-derived drug promising for cancer treatment
Date:12/23/2009

A promising cancer drug, first discovered in a mushroom commonly used in Chinese medicine, could be made more effective thanks to researchers who have discovered how the drug works. The research is funded by the Biotechnology and Biological Sciences Research Council and was carried out at The University of Nottingham.

In research to be published in the Journal of Biological Chemistry, Dr Cornelia de Moor of The University of Nottingham and her team have investigated a drug called cordycepin, which was originally extracted from a rare kind of wild mushroom called cordyceps and is now prepared from a cultivated form.

Dr de Moor said: "Our discovery will open up the possibility of investigating the range of different cancers that could be treated with cordycepin. We have also developed a very effective method that can be used to test new, more efficient or more stable versions of the drug in the Petri dish. This is a great advantage as it will allow us to rule out any non-runners before anyone considers testing them in animals."

Cordyceps is a strange parasitic mushroom that grows on caterpillars (see image). Properties attributed to cordyceps mushroom in Chinese medicine made it interesting to investigate and it has been studied for some time. In fact, the first scientific publication on cordycepin was in 1950. The problem was that although cordycepin was a promising drug, it was quickly degraded in the body. It can now be given with another drug to help combat this, but the side effects of the second drug are a limit to its potential use.

Dr de Moor continued: "Because of technical obstacles and people moving on to other subjects, it's taken a long time to figure out exactly how cordycepin works on cells. With this knowledge, it will be possible to predict what types of cancers might be sensitive and what other cancer drugs it may effectively combine with. It could also lay the groundwork for the design of new cancer drugs that work on the same principle."

The team has observed two effects on the cells: at a low dose cordycepin inhibits the uncontrolled growth and division of the cells and at high doses it stops cells from sticking together, which also inhibits growth. Both of these effects probably have the same underlying mechanism, which is that cordycepin interferes with how cells make proteins. At low doses cordycepin interferes with the production of mRNA, the molecule that gives instructions on how to assemble a protein. And at higher doses it has a direct impact on the making of proteins.

Professor Janet Allen, BBSRC Director of Research said: "Research to understand the underlying bioscience of a problem is always important. This project shows that we can always return to asking questions about the fundamental biology of something in order to refine the solution or resolve unanswered questions. The knowledge generated by this research demonstrates the mechanisms of drug action and could have an impact on one of the most important challenges to health."


'/>"/>

Contact: Nancy Mendoza
press.office@bbsrc.ac.uk
44-179-341-3355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related medicine news :

1. Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs
2. New model of skin cancer provides insights on second-most common type of cancer
3. ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download
4. Neuroimaging provides insights into new treatment options for Alzheimers disease
5. Former House Speaker Newt Gingrich Shares Insights on Healthcare Reform and the Federal Pay Czar with BulletproofBlog.com
6. New Advances and Insights in Gastroenterology Presented at Colleges 74th Annual Meeting
7. PAREXEL Experts to Present Leading Insights at Drug Information Association Annual Clinical Forum
8. Center for Patient Insights Web Site Goes Live
9. Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community
10. Preventing Fungal Infections in HSCT Recipients: Insights from Clinical Cases
11. Mars Veterinary Offers New Insights Into Mixed-Breed Dogs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... portfolio company, today announced it has acquired the assets of Frankfurt, Germany ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... physical therapist assistants, under direct supervision of a licensed physical therapist, to render ... receives a consultation and treatment plan from a licensed physical therapist (PT) and ...
(Date:12/5/2016)... ... 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and Dr. ... do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners or ... a renaissance and every other month a new treatment or device is launched, promising ...
(Date:12/5/2016)... ... December 05, 2016 , ... Z-Medica, LLC, a leading ... with The American College of Surgeons (ACS) to provide basic bleeding control instructor ... Control Basic” course is a pilot program that fulfills the intent of the ...
(Date:12/4/2016)... ... December 03, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... A Wine Tasting Event in New York City, with long-time partners The Paul ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... PITTSBURGH , Dec. 5, 2016  Wellbridge Health and ... innovative digital health solutions to Medicare and Medicaid plan members ... effort targeted at the unique needs of this group of ... on social work philosophies to provide insight into members, daily ... , ...
(Date:12/5/2016)... WOONSOCKET, R.I. , Dec. 5, 2016 /PRNewswire/ ... CVS ) Research Institute and the U.S. ... the Assistant Secretary for Preparedness and Response (ASPR), ... showed that automated pharmacy notifications encourage patients ... a forecasted natural disaster. The study also affirms ...
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
Breaking Medicine Technology: